The ubiquitin‒proteasome degradation system seems to play a critical role in regulating TLE3 levels; however, the mechanisms by which TLE5 is suppressed in metastatic colon and prostate cancers are not fully understood. This evidence concerns the gene TLE3 and prostate carcinoma.